Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Spiegelberg Jasmin Alija |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch, D; Pichler, M
Gender differences in using complementary and alternative medicine in cancer patients: a cross-sectional study
Doctoral Day 2023; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Huemer, M; Pansi, A; Hofmann, G; Terbuch, A; Sciri, E; Lipp, R; Spiegelberg, JA; Jahn-Kuch D; Pichler, M
Gender Differences in Using Complementary and Alternative Medicine in Cancer Patients: A Cross-sectional Study.
EAPC2023 Abstract Book. 2023; 37(1S):92-92.-18th World Congress of the European Association for Palliative Care (EAPC); JUN 15-17, 2023; Rotterdam, NETHERLANDS.
[Poster]
FullText
Barth, D; Stradner, M; Hutterer, H; Spiegelberg, J; Bauernhofer, T; Absenger, G; Jost, P; Pichler, M
Blood-based B-cell subtypes as predictors of treatment response during treatment with immune checkpoint inhibitors: a prospective longitudinal pan-cancer study.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology 2022. 2022; -OeGHO Frühjahrstagung 2022; APR 8-10, 2022; Graz, AUSTRIA.
[Poster]
Huemer, M; Pansi, A; Jahn-Kuch, D; Hofmann, G; Terbuch, A; Sciri, E; Spiegelberg, JA; Lipp, R; Pichler, M
Patterns of use of complementary and alternative medicine in cancer patients: A cross-sectional study
8th International Student Congress; JUN 16-18, 2022; Graz, AUSTRIA. 2022.
[Oral Communication]
Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
Moser, T; Waldispuehl-Geigl, J; Belic, J; Weber, S; Zhou, Q; Hasenleithner, S; Graf, R; Terzic, JA; Posch, F; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Real-time measurements of circulating tumor DNA levels during FOLFOX treatment in patients with colorectal cancer.
4th Annual Meeting of the ÖPPM; Vienna, AUSTRIA. 2020.
[Poster]
Jasmin Terzic*1, Christoph Tinchon2, Herbert Stöger1
Raucherhusten was steckt dahinter?
50. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. Wien Klin Wochenschr 131. 2019; 429-457.-ÖGIM Jahrestagung; Sep 19-21,2019; Salzburg.
[Oral Communication]
FullText
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T;
Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA.
[Poster]
Web of Science
FullText
Terzic, J; Tinchon, C; Stoger, H
Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435.
[Oral Communication]
Web of Science
Seles, M; Fillafer, F; Posch, F; Pichler, M; Terzic, J; Mischinger, J; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Prädiktor bei TKI-Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
Der Urologe 2018, 57 (Suppl 1):S25/26.. 2018; -70. Kongress der Deutschen Gesellschaft für Urologie e.V.; 26.-29.09.2018; Messe Dresden, Deutschland.
[Oral Communication]
Seles, M; Fillafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, GC; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenia can help to predict response to targeted 1st-line therapy in patients with metastatic clear-cell renal cell carcinoma
Central European Meeting/European Association of Urology.; OCT 11-12,2018.; Cluj,ROMANIA.. 2018.
[Poster]
Seles, M; Fillhafer, F; Posch, F; Terzic, J; Pichler, M; Hutterer, G; Zigeuner, R; Pummer, K; Bauernhofer, T
Lymphopenie als Vorhersageparameter bei targeted Erstlinientherapie des metastasierten klarzelligen Nierenzellkarzinoms
German Medical Science GMS Publishing House;2018. Doc18urobay051. doi: 10.3205/18urobay051. 2018; -
44. Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie
; 14.-16.06.2018; Rosenheim, Deutschland.
[Oral Communication]
Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Pichler, M; Jahn, S; Stöger, H; Bauernhofer, T
Lymphopenia impairs response to 1st-line therapy with
sunitinib and pazopanib in patients with metastatic clear-cell
renal cell carcinoma.
Oncology Research
and Treatment . 2018; 41(Suppl4):42-43.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie,; SEP 28- OCT 2, 2018; Vienna, AUSTRIA. (ISBN: 978-3-318-06425-4 )
[Oral Communication]
Web of Science
FullText